Inmune Bio, Inc. — Form D
Inmune Bio, Inc. of La Jolla, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-10. The offering totals $4.7M, of which $4.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2019-05-10
- Form: D
- Accession: 0001640334-19-000800
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.7M
- Amount sold: $4.7M
- Investors: 5
- Date of first sale: 2019-04-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-339273
Issuer
- Name: Inmune Bio, Inc.
- CIK: 0001711754
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2015
- Address: 1224 Prospect Street, Suite 150, La Jolla, CA, 92037
- Phone: (858) 964-3720
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| J. Kelly Ganjei | Director | La Jolla, CA |
| Scott Kelly Juda | Director | La Jolla, CA |
| Timothy Kelly Schroeder | Director | La Jolla, CA |
| David Kelly Szymkowski | Director | La Jolla, CA |
| Raymond J Tesi | Director | La Jolla, CA |
| Mark J Lowdell | Executive Officer | La Jolla, CA |
| David J Moss | Executive Officer | La Jolla, CA |
| Raymond J Tesi | Executive Officer | La Jolla, CA |
| David J Moss | Director | La Jolla, CA |
| Mark J Lowdell | Director | La Jolla, CA |
| Terry R Knapp | Director | La Jolla, CA |
Other filings by this issuer (1)
More